BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2021547)

  • 1. Transforming growth factor beta 1 is implicated in the failure of tamoxifen therapy in human breast cancer.
    Thompson AM; Kerr DJ; Steel CM
    Br J Cancer; 1991 Apr; 63(4):609-14. PubMed ID: 2021547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of tamoxifen resistance of human breast carcinomas in vivo by neutralizing antibodies to transforming growth factor-beta.
    Arteaga CL; Koli KM; Dugger TC; Clarke R
    J Natl Cancer Inst; 1999 Jan; 91(1):46-53. PubMed ID: 9890169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in expression of transforming growth factor beta mRNA isoforms in patients undergoing tamoxifen therapy.
    MacCallum J; Keen JC; Bartlett JM; Thompson AM; Dixon JM; Miller WR
    Br J Cancer; 1996 Aug; 74(3):474-8. PubMed ID: 8695368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the oestrogen regulated pNR-2 mRNA in human breast cancer: relation to oestrogen receptor mRNA levels and response to tamoxifen therapy.
    Henry JA; Nicholson S; Hennessy C; Lennard TW; May FE; Westley BR
    Br J Cancer; 1990 Jan; 61(1):32-8. PubMed ID: 2153395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tamoxifen on transcriptional level of transforming growth factor beta (TGF-beta) isoforms 1 and 2 in tumor tissue during primary treatment of patients with breast cancer.
    Brandt S; Kopp A; Grage B; Knabbe C
    Anticancer Res; 2003; 23(1A):223-9. PubMed ID: 12680217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression in oestrogen-dependent human breast cancer xenograft tumours.
    Thompson AM; Steel CM; Foster ME; Kerr D; Paterson D; Deane D; Hawkins RA; Carter DC; Evans HJ
    Br J Cancer; 1990 Jul; 62(1):78-84. PubMed ID: 2390487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
    Vendrell JA; Robertson KE; Ravel P; Bray SE; Bajard A; Purdie CA; Nguyen C; Hadad SM; Bieche I; Chabaud S; Bachelot T; Thompson AM; Cohen PA
    Breast Cancer Res; 2008; 10(5):R88. PubMed ID: 18928543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pure antiestrogen, ICI 182,780, stimulates the growth of tamoxifen-resistant KPL-1 human breast cancer cells in vivo but not in vitro.
    Kurebayashi J; Otsuki T; Yamamoto S; Kurosumi M; Nakata T; Akinaga S; Sonoo H
    Oncology; 1998 Dec; 55 Suppl 1():23-34. PubMed ID: 9852399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of transforming growth factor-beta responsiveness in the tamoxifen growth-inhibited human breast cancer cell line CAMA-1.
    Ji H; Stout LE; Zhang Q; Zhang R; Leung HT; Leung BS
    J Cell Biochem; 1994 Mar; 54(3):332-42. PubMed ID: 8200913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of endocrine therapy on growth of T61 human breast cancer xenografts is directly correlated to a specific down-regulation of insulin-like growth factor II (IGF-II).
    BrĂ¼nner N; Yee D; Kern FG; Spang-Thomsen M; Lippman ME; Cullen KJ
    Eur J Cancer; 1993; 29A(4):562-9. PubMed ID: 8435211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple forms of TGF-beta 1 in breast tissues: a biologically active form of the small latent complex of TGF-beta 1.
    Baillie R; Coombes RC; Smith J
    Eur J Cancer; 1996 Aug; 32A(9):1566-73. PubMed ID: 8911119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen.
    Boylan M; van den Berg HW; Lynch M
    Ann Oncol; 1998 Feb; 9(2):205-11. PubMed ID: 9553667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and secretion of transforming growth factor beta isoforms by primary cultures of human breast tumour fibroblasts in vitro and their modulation by tamoxifen.
    Benson JR; Wakefield LM; Baum M; Colletta AA
    Br J Cancer; 1996 Aug; 74(3):352-8. PubMed ID: 8695348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of endocrine therapy on the levels of oestrogen and progesterone receptor and transforming growth factor-beta 1 in metastatic human breast cancer: an immunocytochemical study.
    Murray PA; Gomm J; Ricketts D; Powles T; Coombes RC
    Eur J Cancer; 1994; 30A(9):1218-22. PubMed ID: 7999402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen-induced ER-alpha-SRC-3 interaction in HER2 positive human breast cancer; a possible mechanism for ER isoform specific recurrence.
    Mc Ilroy M; Fleming FJ; Buggy Y; Hill AD; Young LS
    Endocr Relat Cancer; 2006 Dec; 13(4):1135-45. PubMed ID: 17158759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen.
    Kok M; Linn SC; Van Laar RK; Jansen MP; van den Berg TM; Delahaye LJ; Glas AM; Peterse JL; Hauptmann M; Foekens JA; Klijn JG; Wessels LF; Van't Veer LJ; Berns EM
    Breast Cancer Res Treat; 2009 Jan; 113(2):275-83. PubMed ID: 18311582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment.
    Butta A; MacLennan K; Flanders KC; Sacks NP; Smith I; McKinna A; Dowsett M; Wakefield LM; Sporn MB; Baum M
    Cancer Res; 1992 Aug; 52(15):4261-4. PubMed ID: 1322240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
    Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA
    Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between tamoxifen-induced transforming growth factor beta 1 expression, cytostasis and apoptosis in human breast cancer cells.
    Perry RR; Kang Y; Greaves BR
    Br J Cancer; 1995 Dec; 72(6):1441-6. PubMed ID: 8519657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth stimulation and differential regulation of transforming growth factor-beta 1 (TGF beta 1), TGF beta 2, and TGF beta 3 messenger RNA levels by norethindrone in MCF-7 human breast cancer cells.
    Jeng MH; Jordan VC
    Mol Endocrinol; 1991 Aug; 5(8):1120-8. PubMed ID: 1834933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.